The Consortium CNAG is constituted under the agreement signed between the General State Administration though the Spanish Ministry of Science, Innovation and Universities (Ministerio de Ciencia, Innovación y Universidades) and the Generalitat de Catalunya through the Catalan Ministry of Research and Universities and the Catalan Ministry of Health (Departament de Recerca i Universitats i Departament de Salut), for the constitution of the Consortium for the exploitation of the Centro Nacional de Análisis Genómico (CNAG).

 

The main governance boards of CNAG are the Board of Trustees, the Executive Commission and the CNAG Management. The Scientific Advisory Board is composed of distinguished and internationally recognised scientists with extensive scientific expertise. Its members contribute to the ongoing enhancement of the excellence of the center, providing their knowledge to the organisation's future plans. 
 

 

BOARD OF TRUSTEES

 

President

Eva Ortega Paíno, Secretary-General of Research, Ministry of Science, Innovation and Universities (MICIU)

Vice-president

Núria Montserrat Pulido, Councilor of Research and Universities (CG)

MICIU Representatives

Marina Pollán Santamaría, Director of Carlos III Health Institute

José I. Doncel Morales, Deputy Director General of Large Scientific and Technical Facilities

Ángela Fernández Curto, Deputy Subdirectorate of Large Scientific and Technical Facilities

CG Representatives

Joan Gómez Pallarès, Director General of Research

Narcís Pérez de Puig, Secretary-General of the Department of Health

Antoni Plasència i Taradach, Director General of Research and Innovation at the Department of Health

Board of Trustees Secretary

Adrián Moliner Usón, State Lawyer

CNAG Guests

Ivo Gut, Director

David González Gil, Managing Director

 

 

EXECUTIVE COMMISSION

 

President

Joan Gómez Pallarès, Director General of Research

Vice-president

José I. Doncel Morales, Deputy Director General of Large Scientific and Technical Facilities, MICIU

MICIU Representatives

Marta Ortiz, Deputy Director General for Research Networks and Cooperative Centres at ISCIII

CG Representatives

Montserrat Llavayol i Giralt, Deputy Director General for Health Research and Innovation of the Department of Health, CG

Commission Secretary

Adrián Moliner Usón, State Lawyer

CNAG Guests

Ivo Gut, Director

David González Gil, Managing Director

 

 

MANAGEMENT TEAM

 

Ivo Gut, Director

David González Gil, Managing Director

Simon Heath, Chief Information Officer and Bioinformatics Development and Statistical Genomics Team Leader

Marta Gut, Head of the Sequencing Unit

Sergi Beltran, Head of the Bioinformatics Unit

Mònica Bayés, Strategy and Project Manager Coordinator

Marc A. Martí-Renom, Structural Genomics Group Leader

 
 

SCIENTIFIC ADVISORY BOARD

 

Dr. Elías Campo

Director, IDIBAPS, Barcelona
Senior Consultant, Hospital Clinic de Barcelona, Barcelona
Professor, Department of Pathology, Universitat de Barcelona, Barcelona

Dr. Roland Eils

Founding Director, Center for Digital health Berlin Institute of Health at Charité Universitätsmedizin, Berlin
Director Health Data Science Unit, Medical Faculty, University of Heidelberg, Heidelberg

Dr. Sabine Tejpar 

Professor, UZ-KULEUVEN, Leuven

Dr. Toni Andreu

Scientific Director, European insfrastructure for translational medicine (EATRIS), Amsterdam

Dr. Tuuli Lappalainen

Professor
KTH Royal Institute of Technology and SciLifeLab, Stockholm
New York Genome Center, New York
 
 
OMICSTECH ACCESS COMMITTEE
 
CNAG is part of the Infrastructure for Omics Technologies, OmicsTech, along with the Centre for Omics Sciences and the CRG/UPF Proteomics Unit. As a Unique Science and Technology Infrastructure (ICTS), it is composed of an Access Committee, whose main objective is to review applications for large-scale projects, ensuring competitive access. In the field of genomics, the OmicsTech Access Committee consists of the experts listed below.
 
Ivo Gut, CNAG
Elías Campo, H. Clínic/IDIBAPS
Pere Puigdomènech, CRAG
Ángel Carracedo, USC